Mallinckrodt Hit With Cocaine Anesthetic Trade Secret Suit

Law360 (December 2, 2019, 3:30 PM EST) -- A drugmaker that makes a cocaine-based anesthetic is accusing pharmaceutical company Mallinckrodt in Pennsylvania federal court of misappropriating trade secrets on the safety of its pharmaceutical-grade cocaine hydrochloride that is used in the anesthetic to increase the commercial value of its own product.

In a lawsuit filed Friday, Genus Lifesciences Inc. says that Mallinckrodt signed an agreement to supply pharmaceutical-grade raw cocaine hydrochloride, or cocaine HCI, for Genus' local anesthetic drug Goprelto, which is used in nasal cavity medical procedures.

Genus claims it spent a significant amount of money to determine whether the cocaine HCI could be safely used in the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS